BACKGROUND: Candida nivariensis and C. bracarensis have been recently identified as emerging yeast pathogens which are phenotypically indistinguishable from C. glabrata. However, there is little data on the prevalence and antifungal susceptibilities of these species. OBJECTIVE: This study investigated the occurrence of C. nivariensis and C. bracarensis in a culture collection of 185 C. glabrata isolates at a Malaysian teaching hospital. METHODS: C. nivariensis was discriminated from C. glabrata using a PCR assay as described by Enache-Angoulvant et al. (J Clin Microbiol 49:3375-9, 2011). The identity of the isolates was confirmed by sequence analysis of the D1D2 domain and internal transcribed spacer region of the yeasts. The isolates were cultured on Chromogenic CHROMagar Candida (®) agar (Difco, USA), and their biochemical and enzymic profiles were determined. Antifungal susceptibilities of the isolates against amphotericin B, fluconazole, voriconazole and caspofungin were determined using E tests. Clotrimazole MICs were determined using a microbroth dilution method. RESULTS: There was a low prevalence (1.1 %) of C. nivariensis in our culture collection of C. glabrata. C. nivariensis was isolated from a blood culture and vaginal swab of two patients. C. nivariensis grew as white colonies on Chromogenic agar and demonstrated few positive reactions using biochemical tests. Enzymatic profiles of the C. nivariensis isolates were similar to that of C. glabrata. The isolates were susceptible to amphotericin B, fluconazole, voriconazole and caspofungin. Clotrimazole resistance is suspected in one isolate. CONCLUSION: This study reports for the first time the emergence of C. nivariensis in our clinical setting.
BACKGROUND:Candida nivariensis and C. bracarensis have been recently identified as emerging yeast pathogens which are phenotypically indistinguishable from C. glabrata. However, there is little data on the prevalence and antifungal susceptibilities of these species. OBJECTIVE: This study investigated the occurrence of C. nivariensis and C. bracarensis in a culture collection of 185 C. glabrata isolates at a Malaysian teaching hospital. METHODS:C. nivariensis was discriminated from C. glabrata using a PCR assay as described by Enache-Angoulvant et al. (J Clin Microbiol 49:3375-9, 2011). The identity of the isolates was confirmed by sequence analysis of the D1D2 domain and internal transcribed spacer region of the yeasts. The isolates were cultured on Chromogenic CHROMagar Candida (®) agar (Difco, USA), and their biochemical and enzymic profiles were determined. Antifungal susceptibilities of the isolates against amphotericin B, fluconazole, voriconazole and caspofungin were determined using E tests. Clotrimazole MICs were determined using a microbroth dilution method. RESULTS: There was a low prevalence (1.1 %) of C. nivariensis in our culture collection of C. glabrata. C. nivariensis was isolated from a blood culture and vaginal swab of two patients. C. nivariensis grew as white colonies on Chromogenic agar and demonstrated few positive reactions using biochemical tests. Enzymatic profiles of the C. nivariensis isolates were similar to that of C. glabrata. The isolates were susceptible to amphotericin B, fluconazole, voriconazole and caspofungin. Clotrimazole resistance is suspected in one isolate. CONCLUSION: This study reports for the first time the emergence of C. nivariensis in our clinical setting.
Authors: A Enache-Angoulvant; J Guitard; F Grenouillet; T Martin; P Durrens; C Fairhead; C Hennequin Journal: J Clin Microbiol Date: 2011-07-13 Impact factor: 5.948
Authors: Andrew M Borman; Rebecca Petch; Christopher J Linton; Michael D Palmer; Paul D Bridge; Elizabeth M Johnson Journal: J Clin Microbiol Date: 2008-01-16 Impact factor: 5.948
Authors: M C Esposto; A Prigitano; O Romeo; G Criseo; L Trovato; V Tullio; M E Fadda; A M Tortorano Journal: Mycoses Date: 2012-11-21 Impact factor: 4.377
Authors: Shawn R Lockhart; Shawn A Messer; Michael Gherna; Justin A Bishop; William G Merz; Michael A Pfaller; Daniel J Diekema Journal: J Clin Microbiol Date: 2009-02-04 Impact factor: 5.948
Authors: Rogelio de J Treviño-Rangel; José F Espinosa-Pérez; Hiram Villanueva-Lozano; Alexandra M Montoya; Angel Andrade; Alexandro Bonifaz; Gloria M González Journal: Folia Microbiol (Praha) Date: 2018-02-27 Impact factor: 2.099
Authors: Alejandra Zuluaga; Karen Arango-Bustamante; Diego H Caceres; Zilpa A Sánchez-Quitian; Verónica Velásquez; Beatriz L Gómez; Claudia M Parra-Giraldo; Natalia Maldonado; Luz E Cano; Catalina de Bedout; Raúl E Rivera Journal: Colomb Med (Cali) Date: 2018-09-30
Authors: Maria Helena Galdino Figueiredo-Carvalho; Livia de Souza Ramos; Leonardo Silva Barbedo; Alessandra Leal da Silva Chaves; Ilda Akemi Muramoto; André Luis Souza dos Santos; Rodrigo Almeida-Paes; Rosely Maria Zancopé-Oliveira Journal: Mem Inst Oswaldo Cruz Date: 2016-01 Impact factor: 2.743